期刊文献+

Macrophage migration inhibitory factor protects bone marrow mesenchymal stem cells from hypoxia/ischemia-induced apoptosis by regulating lncRNA

原文传递
导出
摘要 Objective:This research was performed to explore the effect of macrophage migration inhibitory factor(MIF)on the apoptosis of bone marrow mesenchymal stem cells(BMSCs)in ischemia and hypoxia environments.Methods:The cell viability of BMSCs incubated under hypoxia/ischemia(H/I)conditions with or without pretreatment with MIF or triglycidyl isocyanurate(TGIC)was detected using cell counting kit-8(CCK-8)analysis.Plasmids containing long noncoding RNA(lncRNA)maternally expressed gene 3(MEG3)orβ-catenin small interfering RNA(siRNA)were used to overexpress or downregulate the corresponding gene,and the p53 signaling pathway was activated by pretreatment with TGIC.The influences of MIF,overexpression of lncRNA MEG3,activation of the p53 signaling pathway,and silencing ofβ-catenin on H/I-induced apoptosis of BMSCs were revealed by western blotting,flow cytometry,and terminal deoxynucleotidyl transferase(TdT)-mediated dUTP nick-end labeling(TUNEL)staining.Results:From the results of CCK-8 assay,western blotting,and flow cytometry,pretreatment with MIF significantly decreased the H/I-induced apoptosis of BMSCs.This effect was inhibited when lncRNA MEG3 was overexpressed by plasmids containing MEG3.The p53 signaling pathway was activated by TGIC,andβ-catenin was silenced by siRNA.From western blot results,the expression levels ofβ-catenin in the nucleus and phosphorylated p53(p-p53)were downregulated and upregulated,respectively,when the lncRNA MEG3 was overexpressed.Through flow cytometry,MIF was also shown to significantly alleviate the increased reactive oxygen species(ROS)level of BMSCs caused by H/I.Conclusions:In summary,we conclude that MIF protected BMSCs from H/I-induced apoptosis by downregulating the lncRNA MEG3/p53 signaling pathway,activating the Wnt/β-catenin signaling pathway,and decreasing ROS levels.
出处 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2022年第12期989-1001,共13页 浙江大学学报(英文版)B辑(生物医学与生物技术)
基金 supported by the National Natural Science Foundation of China(No.81702132) the Zhejiang Provincial Natural Science Foundation of China(No.LY21H060007) the Projects of Medical and Health Technology Program in Zhejiang Province(No.2021KY206) the Wenzhou Public Welfare Scienceand Technology Research Project(Nos.Y20190267 and Y20210436),China.
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部